BACKGROUND: Antidepressant prescribing continues to rise. Contributing factors are increased long-term prescribing and possibly the use of higher selective serotonin re-uptake inhibitor (SSRI) doses. AIM: To review general practice patients prescribed the same antidepressant long-term (≥2 years) and evaluate prescribing and management pre and post-review. DESIGN AND SETTING: Prospective observational cohort study using routine data from 78 urban general practices, Scotland. METHOD: All patients prescribed antidepressants (excluding amitriptyline) for ≥2 years were identified from records November 2009 to March 2010. GPs selected patients for face-to-face review of clinical condition and medication, December 2009 to September 2010. Pre- and post-review data were collected; average antidepressant doses and changes in prescribed daily doses were calculated. Onward referral to support services was recorded. RESULTS: 8.6% (33 312/388 656) of all registered patients were prescribed an antidepressant, 47.1% (15 689) were defined as long-term users and 2849 (18.2%) were reviewed. 811 (28.5%) patients reviewed had a change in antidepressant therapy: 7.0% stopped, 12.8% reduced dose, 5.3% increased dose, and 3.4% changed antidepressant, resulting in 9.5% (95% CI = 9.1% to 9.8% P<0.001) reduction in prescribed daily dose and 8.1% reduction in prescribing costs. 6.3% were referred onwards, half to NHS Mental Health Services. Pre-review SSRI doses were 10-30% higher than previously reported. CONCLUSION: Almost half of all people prescribed antidepressants were long-term users. Appropriate reductions in prescribing can be achieved by reviewing patients. Higher SSRI doses may be contributing to current antidepressant growth.
BACKGROUND: Antidepressant prescribing continues to rise. Contributing factors are increased long-term prescribing and possibly the use of higher selective serotonin re-uptake inhibitor (SSRI) doses. AIM: To review general practice patients prescribed the same antidepressant long-term (≥2 years) and evaluate prescribing and management pre and post-review. DESIGN AND SETTING: Prospective observational cohort study using routine data from 78 urban general practices, Scotland. METHOD: All patients prescribed antidepressants (excluding amitriptyline) for ≥2 years were identified from records November 2009 to March 2010. GPs selected patients for face-to-face review of clinical condition and medication, December 2009 to September 2010. Pre- and post-review data were collected; average antidepressant doses and changes in prescribed daily doses were calculated. Onward referral to support services was recorded. RESULTS: 8.6% (33 312/388 656) of all registered patients were prescribed an antidepressant, 47.1% (15 689) were defined as long-term users and 2849 (18.2%) were reviewed. 811 (28.5%) patients reviewed had a change in antidepressant therapy: 7.0% stopped, 12.8% reduced dose, 5.3% increased dose, and 3.4% changed antidepressant, resulting in 9.5% (95% CI = 9.1% to 9.8% P<0.001) reduction in prescribed daily dose and 8.1% reduction in prescribing costs. 6.3% were referred onwards, half to NHS Mental Health Services. Pre-review SSRI doses were 10-30% higher than previously reported. CONCLUSION: Almost half of all people prescribed antidepressants were long-term users. Appropriate reductions in prescribing can be achieved by reviewing patients. Higher SSRI doses may be contributing to current antidepressant growth.
Authors: John R Geddes; Stuart M Carney; Christina Davies; Toshiaki A Furukawa; David J Kupfer; Ellen Frank; Guy M Goodwin Journal: Lancet Date: 2003-02-22 Impact factor: 79.321
Authors: Emma Maund; Beth Stuart; Michael Moore; Christopher Dowrick; Adam W A Geraghty; Sarah Dawson; Tony Kendrick Journal: Ann Fam Med Date: 2019-01 Impact factor: 5.166
Authors: Renske C Bosman; Klaas M Huijbregts; Peter Fm Verhaak; Henricus G Ruhé; Harm Wj van Marwijk; Anton Jlm van Balkom; Neeltje M Batelaan Journal: Br J Gen Pract Date: 2016-08-15 Impact factor: 5.386
Authors: Ellen Van Leeuwen; Mieke L van Driel; Mark A Horowitz; Tony Kendrick; Maria Donald; An Im De Sutter; Lindsay Robertson; Thierry Christiaens Journal: Cochrane Database Syst Rev Date: 2021-04-15
Authors: Chris F Johnson; Nadine J Dougall; Brian Williams; Stephen A MacGillivray; Alasdair I Buchanan; Richard D Hassett Journal: BMC Fam Pract Date: 2014-12-24 Impact factor: 2.497
Authors: Chris F Johnson; Brian Williams; Stephen A MacGillivray; Nadine J Dougall; Margaret Maxwell Journal: BMC Fam Pract Date: 2017-06-17 Impact factor: 2.497
Authors: Tony Kendrick; Adam W A Geraghty; Hannah Bowers; Beth Stuart; Geraldine Leydon; Carl May; Guiqing Yao; Wendy O'Brien; Marta Glowacka; Simone Holley; Samantha Williams; Shihua Zhu; Rachel Dewar-Haggart; Bryan Palmer; Margaret Bell; Sue Collinson; Imogen Fry; Glyn Lewis; Gareth Griffiths; Simon Gilbody; Joanna Moncrieff; Michael Moore; Una Macleod; Paul Little; Christopher Dowrick Journal: Trials Date: 2020-05-24 Impact factor: 2.279
Authors: Neeltje M Batelaan; Renske C Bosman; Anna Muntingh; Willemijn D Scholten; Klaas M Huijbregts; Anton J L M van Balkom Journal: BMJ Date: 2017-09-13
Authors: Tessa Magnée; Derek P de Beurs; Francois G Schellevis; Peter F Verhaak Journal: Scand J Prim Health Care Date: 2018-01-17 Impact factor: 2.581